Cameco: BMO Lifts Price Target To $42 Following Positive Uranium Price Move

On March 30th, BMO Capital Markets raised their rating and 12-month price target on Cameco (TSX: CCO). BMO raised their rating from market perform to outperform, and increased their price target from $33 to $42. The analyst indicated that the lift was due to the limited number of listed producers, the rise in countries wanting low carbon nuclear generation, and the security of supply becoming a forefront issue.

“Cameco’s advantageous geographical production base and its position as the largest and most liquid uranium stock means there should be further upside to its stock price.”

Cameco currently has 13 analysts covering the stock with an average 12-month price target of C$38.53, which represents a 6% upside to the current stock price. Out of the 13 analysts, 4 have strong buy ratings, 7 have buy ratings while the last 2 analysts have hold rating on the stock. The street high sits at C$45 from TD Securities, which represents a 24% upside to the current price.

BMO has gone ahead and increased its near-term uranium prices by 13% for 2022 and 3% for 2023, to an average of US$51/lb and US$46/lb respectively. For the company, this means that they now expect “a modest” increase in Cameco’s near-term cash flow as well a their EBITDA.

The analyst at BMO says that the change in global sentiment will work out for Cameco, as the support for nuclear power continues to grow in countries all around the world, which means governments are looking at either increasing the lifespan of working nuclear facilities or reopening previously closed nuclear power plants. Either option will increase the near-term demand, which is “underpinning increasingly positive sentiment in the sector.”

Lastly, they add that the tragic events in Ukraine “has brought security of supply into sharper focus,” which includes many commodities such as Uranium, as it offers a low carbon alternative to fossil fuels. BMO believes that due to Cameco’s “advantageous location” as it’s close to the world’s largest nuclear fleet in the U.S, “we believe Cameco is increasingly likely to benefit from positive contracting discussions with utilities following on from the promising start reported this year.”

Below you can see BMO’s updated 2022 and 2023 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Stock Just Doubled — And It Still Looks Cheap | Q-Gold Resources PEA

Silver May Be the Trade of This Crisis | Michael Oliver

Why This Gold Story Still Has Room to Run | Dan Wilton – First Mining Gold

Recommended

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Kirkland Lake Drills 121 Metres Of 1.01 g/t Gold At Mirado

Related News

BMO Lowers Aritzia’s Price Target, Points To Inflation Headwinds

Last week Aritzia (TSX: ATZ) reported their fiscal fourth quarter ending February 26 results. The...

Tuesday, May 10, 2022, 03:02:00 PM

Cameco Lifts Q4 2025 Earnings As Westinghouse Swings Back Positive

Cameco (TSX: CCO) finished 2025 with Q4 revenue of $1.20 billion versus $1.18 billion a...

Friday, February 13, 2026, 09:43:26 AM

Valens Sees Eight Capital, Haywood, Canaccord Slash Price Targets Following Q2 Financials

Last Wednesday, The Valens Company (TSX: VLNS) released its financial statements for the second quarter...

Monday, July 20, 2020, 11:04:54 AM

Teladoc: Mixed Results From Analysts Following Q4 Results

On February 24th, Teladoc Health (NYSE: TDOC) reported their full-year and fourth quarter results. Fourth...

Friday, February 26, 2021, 04:06:40 PM

Cameco Shares Drop On Reported $7 Million Net Loss In Q1 2024

Cameco (TSX: CC0) has released its consolidated financial and operational results for the first quarter...

Tuesday, April 30, 2024, 08:27:47 AM